ImmunityBio’s $40 Million Common Stock Offering

Wilson Sonsini advised ImmunityBio, and Goodwin advised the placement agent.ImmunityBio, Inc. (NASDAQ: IBRX) announced that it has executed financing to provide further working capital and support its…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here